2018
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/&mgr;l
Kong CY, Sigel K, Criss SD, Sheehan DF, Triplette M, Silverberg MJ, Henschke CI, Justice A, Braithwaite RS, Wisnivesky J, Crothers K. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/&mgr;l. AIDS 2018, 32: 1333-1342. PMID: 29683843, PMCID: PMC5991188, DOI: 10.1097/qad.0000000000001818.Peer-Reviewed Original ResearchConceptsLow-dose computed tomographyLung cancer screeningCD4 cell countMedicaid Services criteriaCancer screeningLung cancerMortality reductionCell countLDCT examinationsAnnual low-dose computed tomographyUninfected individualsLung cancer mortality reductionVeterans Aging Cohort StudyCancer mortality reductionAntiretroviral therapy adherenceAging Cohort StudyLung cancer mortalityCells/Lung Cancer Policy ModelMultiple national organizationsAlternative screening strategiesBase-case analysisHIV cohortCohort studyFormer smokers
2014
Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing
Sigel K, Wisnivesky J, Shahrir S, Brown ST, Justice A, Kim J, Rodriguez-Barradas MC, Akgün KM, Rimland D, Hoo GW, Crothers K. Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing. AIDS 2014, 28: 1007-1014. PMID: 24401647, PMCID: PMC4018450, DOI: 10.1097/qad.0000000000000189.Peer-Reviewed Original ResearchConceptsNational Lung Screening TrialNLST criteriaCT findingsLung cancerCT scanHIV-Associated Lung Emphysema (EXHALE) studyAbnormal CT scansCD4 cell countChest CT findingsHigh-risk smokersAbnormal CT findingsLung cancer mortalityBalance of benefitsUninfected participantsUninfected veteransAsymptomatic HIVCD4 cellsAbnormal findingsTomography screeningUnadjusted riskHIV statusMultivariable analysisCancer mortalityChest CTClinical evaluation